Scientists with Deakin’s School of Medicine have found that, when coupled with the milk protein lactoferrin, the chemotherapy drug Doxorubicin (Dox) can be delivered directly into the nucleus of prostate cancer cells and will kill them cells as well as drug resistant cancer stem cells, without any side-effects. Read the article here.
Prostate Cancer Treatment Breakthrough Read More »
A man’s race/ethnicity might influence decision-making regarding opting for active treatment as well as undergoing serial biopsies during active surveillance, according to a recent study. Read the article here.
What influences opting out of active surveillance? Read More »
The treatment, called focal needle ablation, makes use of a needle that can freeze (cryoablation) or use heat (radiofrequency ablation) to destroy cancer cells. Read the article here.
Treating prostate cancer with precision Read More »
Androgen-deprivation therapy (ADT) can be associated with significant psychological effects in patients with prostate cancer. Additionally, these side effects—which include depression, Alzheimer disease, and coronary disease—are often under-reported by patients. Read the article here.
Psychological Effects From ADT a Growing Challenge in Prostate Cancer Read More »
In this video, shared by Continence Foundation of Australia, listen to Specialist Continence & Women’s Health Physiotherapist, Shan Morrison, as she discusses urinary incontinence in men after prostate cancer surgery. Dr. Morrison also talks about pelvic floor exercises and how these can help men in their recovery. Watch the video here.
Prostate Cancer Surgery and Pelvic Floor Exercises: What to Know Read More »
Reducing testosterone levels with androgen deprivation therapy, or A.D.T., is a common treatment for prostate cancer. But a new study has found that it more than doubles the risk of dementia. Read the article here.
Prostate Cancer Treatment Can Raise Dementia Risk Read More »
Robot-assisted and open radical surgeries for prostate cancer have similar outcomes for patients at 3 months, according to clinical trial results published in the Lancet. Read the first article here.
After 16 years, robotic surgery for prostate cancer still is debated Read More »
Brachytherapy, a form of localized radiation therapy, has been shown to be one of the most effective methods for delivering high radiation doses to the cancer; however, recent evidence suggests that increasing the localized radiation dose without bound may cause unacceptable increases in long-term side effects. This review focuses on methods that have been proposed, or are already in clinical use, to safely escalate the dose of radiation within the prostate. Read the article here.
Many men who are told their surgery for prostate cancer has been a success later discover that this is not the case. The level of a protein in their blood, called prostate specific antigen, PSA, begins to rise signalling they still have prostate cells in their body even though they were told the entire prostate had been removed. There has been long standing debate about how best to predict who will fail after surgery. The current debate focuses on the value of pathologists examining the excised prostate and trying to detect, under the microscope, whether tumour cells have invaded the
Predicting if your surgery for prostate cancer will fail Read More »
Howard Wolinsky, a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. After over 5 years of active surveillance, he describes his continuing quest to make the best — and most informed — decision about his care. Read the article here.
Prostate Cancer: New Directions With Active Surveillance Read More »